Skip to main content

Advertisement

SpringerLink
Log in

Renal cell carcinoma and arterial hypertension

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The association between renal cell carcinoma and arterial hypertension has been the subject of various studies. These studies have not been consistent in clarifying the relationship between the two. Some authors contend that arterial hypertension is a consequence of renal cell carcinoma, which secretes vasoactive peptides. Others claim that arterial hypertension is a risk factor for the development of renal cell carcinoma. The purpose of our study is to assess if there is a direct connection between arterial hypertension and renal cell carcinoma.

Methods

Out of 16,755 patients who were examined by ultrasonography, 40 were diagnosed with renal tumors. Of the 40 patients, 29 had malignant renal tumors, and 11 had benign renal tumors. These diagnoses were confirmed by CT scan, renal biopsy, and histology. Most of the patients with renal cell carcinoma (79.3%) had arterial hypertension. The group with benign renal tumors served as a control group. Out of the 29 patients with malignant renal cell carcinoma, 24 patients were treated with total nephrectomy, one had a partial nephrectomy, and four patients were too unwell for surgical intervention. In the group of those with benign renal tumors, seven patients had partial nephrectomies for the removal of angiomyolipomas. The personal histories were taken at the initiation of the study, and vital signs were obtained before and after surgery. Statistical analyses were performed using the Statistical Package for Social Sciences, version 10.0.

Results

In the malignant group, the systolic blood pressure (SBP) before surgery was 157.41 ± 27.86 mmHg, and the diastolic blood pressure (DBP) was 97.24 ± 15.33 mmHg, while in the benign group, SBP was 134.55 ± 17.53 mmHg, and DBP was 88.18 ± 14.01 mmHg. In the malignant group in those who had undergone nephrectomies, the mean systolic pressure was 136.82, and the diastolic pressure was 85.90. In the benign group, the systolic and diastolic blood pressures were normal before and after surgery.

Conclusion

In the group of patients with both renal cell carcinoma and arterial hypertension, their hypertension was resolved after they underwent nephrectomies. In conclusion, our data suggest that renal cell carcinomas may cause arterial hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol. 1999;149:521–30.

    Article  CAS  PubMed  Google Scholar 

  2. Grove JS, Nomura A, Severson RK, Stemmermann GN. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol. 1999;134:942–7.

    Article  Google Scholar 

  3. Chow WH, Gridley G, Fraumeni JF, Järvholm B. Obesity, hypertension, and the risk of kidney cancer in man. N Engl J Med. 2000;343:1305–11.

    Article  CAS  PubMed  Google Scholar 

  4. Steffens J, Bock R, Braedel HU, Isenberg E, Bührle CP, Ziegler M. Renin-producing renal cell carcinoma-clinical and experimental investigations on a special form of renal hypetension. Urol Res. 1992;20:111–5.

    Article  CAS  PubMed  Google Scholar 

  5. Singh DR, Gaitonde K, Santoshi N, Patil N, Srinivas V. Renal cell carcinoma presenting as hypertension. Indian J Urol. 2002;19:80–1.

    Google Scholar 

  6. Moein MR, Dehghani VO. Hypertension: a rare presentation of renal cell carcinoma. J Urol. 2000;164(6):2019.

    Article  CAS  PubMed  Google Scholar 

  7. Sufrin G, Chasan S, Golio A, Murphy GP. Paraneoplastic and serologic syndromes of renal adenocarcinoma. Semin Urol. 1989;7(3):158–71.

    CAS  PubMed  Google Scholar 

  8. Bolton DM, Wong P, Lawrentschuk N. Renall cell carcinoma: imaging and therapy. Curr Opin Urol. 2007;17(5):337–40.

    Article  PubMed  Google Scholar 

  9. Murai M, Oya M. Renal cell carcinoma: etiology, incidence and epidemiolgy. Curr Opin Urol. 2004;14(4):229–33.

    Article  PubMed  Google Scholar 

  10. Takahashi K, Totsune K, Murakami O. Expression of three vasoactive peptides, urotensin- II, adrenomedullin, and endothelin-1, in a human renal cell carcinoma cell line, VMRC-RCW. Clin Exp Nephrol. 2001;5(4):246–9.

    Article  CAS  Google Scholar 

  11. Touyz RM, Schiffrin EL. Role of endothelin in human hypertension. Canad J Physiol Pharmacol. 2003;81(6):533–41.

    Article  CAS  Google Scholar 

  12. Iglarz M, Schiffrin EL. Role of endothelin-1 in hypertension. Curr Hypertens Rep. 2003;5(2):144–8.

    Article  PubMed  Google Scholar 

  13. Schiffrin EL. Vascular endothelin in hypertension. Vascul Pharmacol. 2005;43(1):19–29.

    Article  CAS  PubMed  Google Scholar 

  14. Feldstein C, Romero C. Role of endothelins in hypertension. Am J Ther. 2007;14(2):147–53.

    Article  PubMed  Google Scholar 

  15. Shreenivas S, Oparil S. The role of endothelin-1 in human hypertension. Clin Hemorheol Microcirc. 2007;37(1–2):157–78.

    CAS  PubMed  Google Scholar 

  16. Pflug BR, Hong Z, Udan MS, D’Antonio JM, Marshall FF, Brooks JD, et al. Endothelin-1 promotes cell-survival in renal cell carcinoma through the ET[A] receptor. Cancer. 2007;246:139–48.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Regional Medical Center and Hospital, Berane, Montenegro

    Milan Stojanovic

  2. Diagnostic Imaging Center KBC “Bezanijska Kosa” Belgrade, School of Medicine, University of Belgrade, 11192 Beograd, Gocka 4, Belgrade, Serbia

    Branislav Goldner

  3. School of Medicine, University of Belgrade, Belgrade, Serbia

    Dusan Ivkovic

Authors
  1. Milan Stojanovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Branislav Goldner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dusan Ivkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Branislav Goldner.

About this article

Cite this article

Stojanovic, M., Goldner, B. & Ivkovic, D. Renal cell carcinoma and arterial hypertension. Clin Exp Nephrol 13, 295–299 (2009). https://doi.org/10.1007/s10157-008-0122-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-008-0122-x

Keywords

Search

Navigation